Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timna Naftali

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cannabis and Cannabinoid Research|October 31, 2017
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in <i>Cannabis</i> ExtractsRameshprabu Nallathambi, Moran Mazuz, Aurel Ion, et al.
Gastroenterology|March 19, 2025
Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled TrialShomron Ben-Horin, Adi Lahat, Bella Ungar, et al.
Journal of Crohn'S & Colitis|September 11, 2023
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II StudySivan Harnik, Chaya M Abitbol, Ola Haj Natour, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2021
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in IsraelIrit Avni-Biron, Ariella Bar-Gil Shitrit, Benjamin Koslowsky, et al.
The American Journal of Gastroenterology|June 6, 2018
Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC StudyBella Ungar, Tal Engel, Doron Yablecovitch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn's disease: the TASTI-E randomized controlled trialLuba Plotkin, Yonat Aharoni-Frutkoff, Daniel Pollak, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cannabis and Cannabinoid Research|October 31, 2017
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in <i>Cannabis</i> ExtractsRameshprabu Nallathambi, Moran Mazuz, Aurel Ion, et al.
Gastroenterology|March 19, 2025
Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled TrialShomron Ben-Horin, Adi Lahat, Bella Ungar, et al.
Journal of Crohn'S & Colitis|September 11, 2023
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II StudySivan Harnik, Chaya M Abitbol, Ola Haj Natour, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2021
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in IsraelIrit Avni-Biron, Ariella Bar-Gil Shitrit, Benjamin Koslowsky, et al.
The American Journal of Gastroenterology|June 6, 2018
Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC StudyBella Ungar, Tal Engel, Doron Yablecovitch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn's disease: the TASTI-E randomized controlled trialLuba Plotkin, Yonat Aharoni-Frutkoff, Daniel Pollak, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 7